The market is set to grow at a CAGR of 31.65 per cent from 2024 to 2034. However, this growth rate may slow down as tariffs ...

The research team found that a Coronavirus surrogate and Infectious Bronchitis Virus (IBV) bind to the negatively charged ...

Over the next four years, the firm will invest between $ 7 million to $ 25 million per company in early growth-stage businesses operating across HealthTech, Life Sciences, MedTech, Healthcare Delivery ...